Literature DB >> 18391919

Review: hepatotoxicity and EGFR inhibition.

Jeyanthi Ramanarayanan1, Ganapathy S Krishnan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18391919

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

Review 1.  Metabolism considerations for kinase inhibitors in cancer treatment.

Authors:  Derek R Duckett; Michael D Cameron
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

2.  Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of Erlotinib.

Authors:  Chun-Zhi Ai; Yong Liu; Wei Li; De-Meng Chen; Xin-Xing Zhu; Ya-Wei Yan; Du-Chu Chen; Yi-Zhou Jiang
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

3.  Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites.

Authors:  Tyler B Hughes; Na Le Dang; Ayush Kumar; Noah R Flynn; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2020-09-16       Impact factor: 4.956
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.